Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

. SPECT measures regional cerebral blood flow (rCBF) which is closely related to brain cell activity. The study showed that treatment with MTC at the 60mg dose eliminated the rCBF decline that was seen in control subjects. The effect was greatest in brain regions that had the most severe tau aggregation pathology, namely the hippocampus and the entorhinal cortex, which are regions affected early and most severely in Alzheimer's.

"This is the first instance of a disease-modifying Alzheimer's therapy that has attained its primary, pre-specified cognitive efficacy target in a clinical trial," said Wischik. "This trial therefore provides the first clinical trial evidence that an Alzheimer's therapy aimed at blocking tau aggregation may be a viable disease-modifying treatment. We now need to confirm this in a larger Phase III trial."

"Our results appear to meet the draft EMEA clinical guidelines for disease-modifying therapy, supported by SPECT and PET evidence of efficacy in brain regions heavily affected by tau pathology," Wischik added.

Proof of Concept Clinical Trial of Souvenaid(TM): A Medical Nutrition Approach to Mild Alzheimer's

People with Alzheimer's exhibit a significant loss of brain synapses, and this loss correlates with the loss of cognitive function. Pre-clinical research using a technique invented by Massachusetts Institute of Technology (MIT) has shown that specific combinations of nutrients can increase synapse formation. Now a double-blind, controlled study with Souvenaid(TM), including these nutrients, has shown it may help patients with mild Alzheimer's Disease.

Souvenaid(TM), developed by Danone Research - Centre for Specialised Nutrition, is designed to improve synapse formation and synaptic transmission via the synergistic action of a combination of nutrients (specifically, it contains uridine monophosphate, choline, the omega-3 fatty acids (EPA, DHA), phospholipids, B vitamins and antioxidants). Pre-clinical re
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... ranibizumab was approved by CFDA to treat wet age- ... a product of Novartis, is available in the Chinese ... developed drug for the treatment of wet AMD in ...
(Date:8/28/2015)... PRINCETON, N.J. , Aug. 28, 2015  IP Shakti, ... Prediqtus, LLC. ... "Our new corporate identity signifies our ... the world,s first predictive analytics platform for patent claim validity." ... with the launch of the proprietary AIA Shield™ platform, the ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Investigation Report on China's Ranibizumab Market, 2012-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
(Date:8/30/2015)... ... 2015 , ... The law firm of Tomasik Kotin ... recently elected to membership in the American Board of Trial Advocates (ABOTA). ... outstanding professionalism. , ABOTA is an invitation-only, national organization comprised of judges ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... Natural Rest ... beneficial effects as sleep aids and calming remedies, which help to improve mood disorders ... of a great deal of research in the field of regenerative medicine conducted by ...
(Date:8/29/2015)... ... ... Rio Salado College President Chris Bustamante announced on Aug. 19 ... Initiatives and Information Services. O’Shea, who has served Rio Salado for the last two ... through innovative technologies and strategies. , “I am very proud to be able to ...
(Date:8/29/2015)... PA (PRWEB) , ... August 29, 2015 , ... ... due to insufficient scrotal support and protection against dribbled urine and sweat. "In ... from Manhasset Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ProDrop Particles includes ... Each preset contains 15 seconds of unique footage that users can shrink and stretch ... zoom, attract and more. Users can customize color, brightness, scale, speed, range, and flare ...
Breaking Medicine News(10 mins):Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... THURSDAY, Feb. 23 (HealthDay News) -- Children with ... attention-deficit hyperactivity disorder (ADHD) and other related disorders, but ... Researchers analyzed data from more than 1,000 U.S. teens ... of psychiatric medications in those with autism, ADHD and ...
... Reinberg HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay ... but this winter,s flu season is finally here, say experts ... They report that flu activity picked up in the past ... influenza season since 1987-1988. Lab-confirmed cases of influenza have now ...
... CINCINNATI Scientists have developed a unique compound ... blood cells known to fuel ailments like cancer ... Past attempts to identify new compounds ... molecules in cells have been complicated by toxicity ...
... WEDNESDAY, Feb. 22 (HealthDay News) -- Melanoma that has spread ... but a new drug appears to double survival for those ... A mutation in the BRAF protein occurs in about ... a drug approved by the U.S. Food and Drug Administration ...
... Feb. 23 (HealthDay News) -- The first molecular evidence linking ... death could lead to new methods of diagnosis and therapy ... study suggests. Abnormal heart rhythms called ventricular arrhythmias are ... the primary cause of death from heart disease. Experts have ...
... HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay News) -- ... might just be the beginning of your spring allergies ... had warmer-than-average winter weather, which is causing trees to ... Stanley Fineman, president of the American College of Allergy, ...
Cached Medicine News:Health News:Meds for Autism Not Well Understood: Study 2Health News:Flu Season Off to a Very Late Start: CDC 2Health News:New class of compounds stops disease-fueling inflammation in lab tests 2Health News:New class of compounds stops disease-fueling inflammation in lab tests 3Health News:New Melanoma Drug May Extend Survival 2Health News:New Melanoma Drug May Extend Survival 3Health News:Study Links 'Body Clock' to Sudden Cardiac Death 2Health News:Mild Winter Heralds Early Sneezin' Season 2Health News:Mild Winter Heralds Early Sneezin' Season 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: